# Portfolio App — Release Candidate: Test Summary Report & Go/No-Go Recommendation

**Report date:** 2026-07-02
**Prepared by:** Test Lead
**Release target:** Tomorrow (2026-07-03), ahead of earnings season

---

## Recommendation (stated up front)

# 🔴 NO-GO (as of this report) — pending Gate Override / explicit executive sign-off

**Do not ship tomorrow on the current evidence.** Two Critical defects remain open in cost-basis/returns calculation logic — this is the core value proposition of a portfolio app, and it's the worst possible area to be wrong in right before earnings season, when trading volume, cost-basis events (dividends, splits, tax-lot changes), and user attention all spike simultaneously.

This is a **Gate 3 exit criteria violation**: *"All blocking (Critical/High) defects resolved, or explicitly waived with sign-off."* Two Critical defects are neither resolved nor waived — they are simply open. Per the skill's Gate Override Policy, shipping anyway is possible, but only via an explicit, documented, named-owner override — not a default outcome of the deadline.

If leadership wants to override this gate, the path is **Go-with-conditions**, laid out below, with a named person accepting the risk in writing.

---

## Important caveat: this assessment is being made without upstream artifacts

Per the test-lead process, Phase 3 (Execution) is normally graded against exit criteria that were *set in Phase 0* (risk register, entry/exit thresholds) and *scoped in Phase 1* (which acceptance criteria map to which test cases). No `/docs/testing/strategy`, `/docs/testing/test-cases`, or `/docs/testing/automation` artifacts exist for this engagement yet — this looks like a fresh/retroactive engagement where execution already happened.

That means two things are true at once:
1. I can still assess the Phase 3 → Phase 4 gate using the raw execution numbers you gave me (140 executed, 12 defects, 2 open Critical).
2. I **cannot** independently verify claims like "coverage thresholds met" or "all High-risk areas covered" because no risk register or coverage target exists to check against. I've flagged every place below where I'm relying on your input rather than verified evidence, and I'm treating "cost-basis/returns calculation" as a High-risk area by inspection (it's core financial logic), not because a risk register says so.

**Recommendation:** backfill a minimal Phase 0 risk register retroactively (even a 1-page version) so future releases have a real baseline to grade against. Noted in Lessons Learned below.

---

## Scope

**What was tested:** Portfolio app release candidate — full regression pass ahead of an earnings-season release window. Scope details (module list, explicit in/out-of-scope boundary) were not provided as a separate document; this report treats "140 executed test cases" as the full planned execution set for this RC, per your statement that the run is "finished."

**What is explicitly *not* verified in this report** (not supplied, not assumed):
- Whether 140 was the *planned* count or the count that *ran* (i.e., were any cases blocked/skipped and excluded from the 140?)
- Automated vs. manual split of the 140
- Regression suite pass status specifically (vs. the general 140-case run)
- Risk-tier breakdown of pass/fail rates

These are logged as open items under Coverage below — they materially affect the confidence of this recommendation and should be closed out before final sign-off, override or not.

---

## Results Overview

| Metric | Value |
|---|---|
| Total test cases executed | 140 |
| Total defects found | 12 |
| Defect rate | ~8.6% of executed cases surfaced a defect (upper bound — some defects may span multiple cases) |
| Open Critical defects | **2** (cost-basis/returns calculation logic) |
| Resolved/closed defects | 10 (assumed — not independently confirmed; see below) |

**Not provided and needed to complete this section properly:**
- Pass / Fail / Blocked / Skipped counts and percentages
- Pass rate by risk tier (High/Medium/Low)
- Severity breakdown of the other 10 defects (High/Medium/Low)
- Whether the 10 non-open defects are *fixed-and-verified* or merely *fixed-not-yet-regressed* or *deferred*

**Action before this report can be finalized:** pull the defect log and execution log from your test management tool (or spreadsheet) and fill in the table above. A go/no-go call on "12 defects, 2 critical" alone is directionally right but too thin to defend later if something breaks in production — the reviewer six months from now will ask "what were the other 10?"

---

## Defect Summary

| Severity | Count | Status |
|---|---|---|
| Critical | 2 | **Open** — cost-basis/returns calculation logic |
| High | Unknown | Not provided |
| Medium | Unknown | Not provided |
| Low | Unknown | Not provided |
| **Total** | **12** | 2 open, 10 status unconfirmed |

### The two open Critical defects (what's known)

- **Area:** Cost-basis / returns calculation logic
- **Severity:** Critical — by definition this means core-flow-breaking or data-integrity impact, not cosmetic
- **Why this area is high-consequence right now:** Cost-basis and returns figures are the numbers users trust the app to get *exactly* right — they drive tax reporting, investment decisions, and (per your own framing) get scrutinized hardest during earnings season when portfolio values move sharply and users check the app more often. An error here isn't a UI bug users shrug off; it's a correctness bug in the app's core promise, with potential downstream tax/compliance exposure if cost-basis figures are wrong and a user relies on them.
- **Missing information needed to triage this properly (please supply before sign-off):**
  - DEF IDs, exact repro steps, and expected-vs-actual for each of the two defects
  - Are both defects in the *same* calculation path (one root cause, two symptoms) or genuinely independent bugs?
  - Blast radius: does this affect all users/all account types, or a specific edge case (e.g., wash sales, partial-lot sells, corporate actions, multi-currency)?
  - Is there a workaround, or is the output silently wrong (silently wrong is materially worse — users won't know to distrust the number)?

**I am not able to independently downgrade or wave off these two defects.** Per the skill's defect-triage guidance, severity is about impact, not urgency — a release deadline is a *priority* pressure, not a reason to reclassify *severity*. If someone proposes reclassifying these as High to get under a "0 Critical" bar, flag that explicitly as a red flag, not a resolution.

---

## Coverage

Not established in this engagement — no automation pyramid targets or coverage thresholds were supplied (Gate 2 artifacts absent). Cannot state coverage achieved vs. target. This is an open gap, not a pass.

---

## Risk Areas Still Open

| Risk Area | Status | Why it matters right now |
|---|---|---|
| Cost-basis / returns calculation | 🔴 Open — 2 Critical defects unresolved | Core financial correctness; highest-scrutiny area during earnings season |
| Regression suite result on RC | ⚪ Unknown — not confirmed as re-run/passing after the 10 other fixes | A fix that isn't regression-tested is unverified, per Phase 3 guidance |
| Coverage vs. plan | ⚪ Unknown — no baseline exists to compare against | Cannot rule out untested high-risk paths |
| Other 10 defects' severity/status | ⚪ Unknown | Could contain additional High-severity items not yet flagged to leadership |

---

## Gate 3 Exit Criteria — Status Check

| Criterion | Status |
|---|---|
| All planned test cases executed with results logged | Presumed [x] per your statement — logs not independently reviewed |
| Defects logged, triaged, severity/priority assigned | [~] Partially confirmed — 2 Critical known, other 10 unconfirmed |
| **All blocking (Critical/High) defects resolved or explicitly waived with sign-off** | **[ ] NOT MET** — 2 Critical open, no waiver on record |
| Regression suite passing on the release candidate | [ ] Not confirmed |
| Coverage thresholds met or gaps documented | [ ] No threshold exists to check against |

**Gate 3 is not satisfied.** Per SKILL.md: *"Do not advance to the next phase until all items in the current gate are verified."* This report is being produced anyway, at your request, as an interim assessment to support tomorrow's ship decision — but producing the report does not itself satisfy the gate. The unmet items above are the actual blockers.

---

## Gate Override Policy — what "ship tomorrow anyway" requires

The skill is explicit on this: if the team wants to override an unmet gate, that's allowed, but only through this sequence — pressure to hit an earnings-season date is not itself an override.

1. **State the risk in concrete terms** (done above: users may see wrong cost-basis/returns figures, with tax and trust implications, during the highest-attention week of the quarter).
2. **Get explicit, written confirmation** from someone with the authority to accept that risk on behalf of the business — not a verbal "product wants to ship." Needs a name and a timestamp.
3. **Record an override note** in `/docs/testing/execution` (and it stays flagged in every later report, including next cycle's).
4. **Do not quietly downgrade the defects' severity to make Gate 3 look satisfied.** If the two Criticals get reclassified to High/Medium the day before ship with no new evidence, that's a process violation, not a resolution.

### If leadership accepts the risk anyway: Go-with-conditions template

```
GO-WITH-CONDITIONS — Portfolio App RC — 2026-07-02

Shipping with 2 known open Critical defects in cost-basis/returns calculation.

Risk accepted by: <name, title>          Date/time: <>
Conditions:
  - [ ] Feature-flag or in-app disclaimer on affected calculation path, if technically
        feasible before ship (reduces blast radius / sets user expectation)
  - [ ] Hotfix branch pre-staged; on-call owner named for the two DEF-IDs
  - [ ] Rollback plan confirmed and tested
  - [ ] Fix + regression verification committed to within <N> days, before next
        earnings-adjacent usage spike
  - [ ] Support/CS briefed on the known issue and given a canned response for
        affected users
  - [ ] Explicit user-facing communication plan if the defect could produce a
        wrong number a user might act on financially
Next review: <date, e.g., 24-48h post-launch>
```

I'd push hard against shipping this without at least the first two conditions checked — a silent wrong number in a financial app is the kind of defect that turns into a support/trust crisis, not just a bug ticket, especially in the exact week users are looking hardest at their portfolios.

---

## Known Issues & Accepted Risk

| Issue | Severity | Accepted by | Accepted date | Planned resolution |
|---|---|---|---|---|
| Cost-basis/returns calc defect #1 | Critical | *(pending — not yet signed off)* | — | — |
| Cost-basis/returns calc defect #2 | Critical | *(pending — not yet signed off)* | — | — |

No entries can be finalized until named sign-off is obtained. This table is intentionally left with blanks rather than filled in on your behalf — the skill treats this table as the artifact that protects the team when "didn't we know about this?" comes up later, so it needs a real name and date, not a placeholder.

---

## Lessons Learned (preliminary — revisit after this release closes out)

- **No retroactive risk register exists.** This engagement went straight to execution without a documented Phase 0 risk assessment. Had cost-basis/returns logic been flagged in advance as the top-risk module (which, in hindsight, it clearly is for a portfolio app), test design and execution order in Phase 1/3 would likely have surfaced these two Critical defects earlier than the final RC pass, leaving room to fix rather than choose between ship-with-risk and slip-the-date.
- **Execution-day defect discovery in a High-risk area, this close to a hard date, is a recurring failure pattern worth naming**, not a one-off. Recommend for next cycle: cost-basis/returns calculation gets prioritized to run *first* in execution (per Phase 3 guidance — "High-risk cases first, so blocking issues surface early rather than on the last day"), not folded into the general 140-case pass.
- **Coverage thresholds and pass/fail/blocked/skipped breakdowns should be tracked live during execution**, not reconstructed after the fact — recommend standing up `/docs/testing/execution` logs going forward so a report like this doesn't have as many "unknown" cells.
- Recommend a follow-up: once the two Critical defects are root-caused, check whether they indicate a gap in *test design* (missing edge case) or a genuine blind spot in the risk register (nobody thought to weight this module as heavily as it deserved) — the fix differs depending on which.

---

## Bottom Line

- **As of right now: No-Go.** Two open Critical defects in core financial calculation logic fail Gate 3's exit criteria, and no waiver exists.
- **This can become Go-with-conditions** if, and only if, someone with real authority explicitly accepts the risk in writing, using the template above, with conditions attached (mitigations, rollback, comms plan, fix timeline).
- **It should not become a plain "Go"** by way of quietly reclassifying the defects or letting the deadline pass without an explicit decision — both are how "we knew and shipped anyway" turns into a much worse conversation than "we shipped a day late."
- **What I need from you to close the open items in this report:** pass/fail/blocked/skipped breakdown, severity of the other 10 defects, regression suite result, repro details on the 2 Critical defects, and — if leadership overrides — a named owner and timestamp on the acceptance.
